Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

GSK comes close to creating a hard-to-reach RSV vaccine

GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the vaccine was...

Bluejay Diagnostics shares down 31% after rising Thursday

Bluejay Diagnostics Inc. shares reversed course from Thursday's gains, dropping 31% to $1.12 one day after saying the Food and Drug Administration has agreed...

Moderna fell, Novavax rose – positive vaccine news caused mixed reactions

Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines. Moderna stock...

3D deep-learning research company Charm Therapeutics launches with $50m series A

CHARM Therapeutics (“CHARM”, “The Company”), announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos...

Bavarian Nordic expects new orders for monkeypox vaccine due to strong interest

Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its...

Novavax’s COVID-19 vaccine received FDA AdCom approval, clearing “serious hurdles”

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...
spot_img

Expert Articles

spot_img